Loading…

The Regulation of Pyroptosis and Ferroptosis by MicroRNAs in Cardiovascular Diseases

Cardiovascular diseases (CVDs) are considered the most prevalent noncommunicable disease and the leading cause of death worldwide. A plethora of evidence has revealed that microRNAs (miRNAs) could control the inhibition or progression of CVDs by regulating pivotal cell processes ranging from metabol...

Full description

Saved in:
Bibliographic Details
Published in:Galen 2023-08, Vol.12
Main Authors: Faramarzzadeh, Reza, Shariati, Akram, Shahabi Raberi, Venous, Masumi, Mehdi, Tarbiat, Ali, Rastgoo, Elham
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c843-95bc5db7ab2b69c96b59b1a1bc49ab7006a2c5d6fd432c98bf67679687d8393e3
cites
container_end_page
container_issue
container_start_page
container_title Galen
container_volume 12
creator Faramarzzadeh, Reza
Shariati, Akram
Shahabi Raberi, Venous
Masumi, Mehdi
Tarbiat, Ali
Rastgoo, Elham
description Cardiovascular diseases (CVDs) are considered the most prevalent noncommunicable disease and the leading cause of death worldwide. A plethora of evidence has revealed that microRNAs (miRNAs) could control the inhibition or progression of CVDs by regulating pivotal cell processes ranging from metabolism and homeostasis to programmed cell death (PCD). Pyroptosis and ferroptosis are two major types of nonapoptotic PCDs involved in the pathogenesis of heart failure. However, no study has discussed the crosstalk between miRNAs and these two types of PCDs in the CVDs. The current review demonstrated that different types of miRNAs can regulate both ferroptosis and pyroptosis and thereby affect CVDs progression and inhibition. Altogether, the discussed content encourages further studies to confirm that mentioned pathways are suitable to be considered as novel therapeutic approaches against CVDs.
doi_str_mv 10.31661/gmj.v12i.2933
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_31661_gmj_v12i_2933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_31661_gmj_v12i_2933</sourcerecordid><originalsourceid>FETCH-LOGICAL-c843-95bc5db7ab2b69c96b59b1a1bc49ab7006a2c5d6fd432c98bf67679687d8393e3</originalsourceid><addsrcrecordid>eNo9kE9LAzEQxYMoWGqvnvMFdk0yu9nkWFarhfqHsveQZLM1pW1KUgv77U1VPM0MvDe890PonpISKOf0YbPflmfKfMkkwBWaMGCsYNDI67zXQhSs4c0tmqW0JYRQCgC8nqCu-3R47TZfO33y4YDDgD_GGI6nkHzC-tDjhYv_txnxq7cxrN_mCfsDbnXsfTjrZLM_4kefnE4u3aGbQe-Sm_3NKeoWT137Uqzen5ftfFVYUUEha2Pr3jTaMMOlldzU0lBNja2kNg0hXLMs4ENfAbNSmIHnCpKLphcgwcEUlb9vc6KUohvUMfq9jqOiRP1QUZmKulBRFyrwDc34Vy8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Regulation of Pyroptosis and Ferroptosis by MicroRNAs in Cardiovascular Diseases</title><source>PubMed (Medline)</source><creator>Faramarzzadeh, Reza ; Shariati, Akram ; Shahabi Raberi, Venous ; Masumi, Mehdi ; Tarbiat, Ali ; Rastgoo, Elham</creator><creatorcontrib>Faramarzzadeh, Reza ; Shariati, Akram ; Shahabi Raberi, Venous ; Masumi, Mehdi ; Tarbiat, Ali ; Rastgoo, Elham</creatorcontrib><description>Cardiovascular diseases (CVDs) are considered the most prevalent noncommunicable disease and the leading cause of death worldwide. A plethora of evidence has revealed that microRNAs (miRNAs) could control the inhibition or progression of CVDs by regulating pivotal cell processes ranging from metabolism and homeostasis to programmed cell death (PCD). Pyroptosis and ferroptosis are two major types of nonapoptotic PCDs involved in the pathogenesis of heart failure. However, no study has discussed the crosstalk between miRNAs and these two types of PCDs in the CVDs. The current review demonstrated that different types of miRNAs can regulate both ferroptosis and pyroptosis and thereby affect CVDs progression and inhibition. Altogether, the discussed content encourages further studies to confirm that mentioned pathways are suitable to be considered as novel therapeutic approaches against CVDs.</description><identifier>ISSN: 2588-2767</identifier><identifier>EISSN: 2322-2379</identifier><identifier>DOI: 10.31661/gmj.v12i.2933</identifier><language>eng</language><ispartof>Galen, 2023-08, Vol.12</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c843-95bc5db7ab2b69c96b59b1a1bc49ab7006a2c5d6fd432c98bf67679687d8393e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids></links><search><creatorcontrib>Faramarzzadeh, Reza</creatorcontrib><creatorcontrib>Shariati, Akram</creatorcontrib><creatorcontrib>Shahabi Raberi, Venous</creatorcontrib><creatorcontrib>Masumi, Mehdi</creatorcontrib><creatorcontrib>Tarbiat, Ali</creatorcontrib><creatorcontrib>Rastgoo, Elham</creatorcontrib><title>The Regulation of Pyroptosis and Ferroptosis by MicroRNAs in Cardiovascular Diseases</title><title>Galen</title><description>Cardiovascular diseases (CVDs) are considered the most prevalent noncommunicable disease and the leading cause of death worldwide. A plethora of evidence has revealed that microRNAs (miRNAs) could control the inhibition or progression of CVDs by regulating pivotal cell processes ranging from metabolism and homeostasis to programmed cell death (PCD). Pyroptosis and ferroptosis are two major types of nonapoptotic PCDs involved in the pathogenesis of heart failure. However, no study has discussed the crosstalk between miRNAs and these two types of PCDs in the CVDs. The current review demonstrated that different types of miRNAs can regulate both ferroptosis and pyroptosis and thereby affect CVDs progression and inhibition. Altogether, the discussed content encourages further studies to confirm that mentioned pathways are suitable to be considered as novel therapeutic approaches against CVDs.</description><issn>2588-2767</issn><issn>2322-2379</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNo9kE9LAzEQxYMoWGqvnvMFdk0yu9nkWFarhfqHsveQZLM1pW1KUgv77U1VPM0MvDe890PonpISKOf0YbPflmfKfMkkwBWaMGCsYNDI67zXQhSs4c0tmqW0JYRQCgC8nqCu-3R47TZfO33y4YDDgD_GGI6nkHzC-tDjhYv_txnxq7cxrN_mCfsDbnXsfTjrZLM_4kefnE4u3aGbQe-Sm_3NKeoWT137Uqzen5ftfFVYUUEha2Pr3jTaMMOlldzU0lBNja2kNg0hXLMs4ENfAbNSmIHnCpKLphcgwcEUlb9vc6KUohvUMfq9jqOiRP1QUZmKulBRFyrwDc34Vy8</recordid><startdate>20230830</startdate><enddate>20230830</enddate><creator>Faramarzzadeh, Reza</creator><creator>Shariati, Akram</creator><creator>Shahabi Raberi, Venous</creator><creator>Masumi, Mehdi</creator><creator>Tarbiat, Ali</creator><creator>Rastgoo, Elham</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20230830</creationdate><title>The Regulation of Pyroptosis and Ferroptosis by MicroRNAs in Cardiovascular Diseases</title><author>Faramarzzadeh, Reza ; Shariati, Akram ; Shahabi Raberi, Venous ; Masumi, Mehdi ; Tarbiat, Ali ; Rastgoo, Elham</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c843-95bc5db7ab2b69c96b59b1a1bc49ab7006a2c5d6fd432c98bf67679687d8393e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Faramarzzadeh, Reza</creatorcontrib><creatorcontrib>Shariati, Akram</creatorcontrib><creatorcontrib>Shahabi Raberi, Venous</creatorcontrib><creatorcontrib>Masumi, Mehdi</creatorcontrib><creatorcontrib>Tarbiat, Ali</creatorcontrib><creatorcontrib>Rastgoo, Elham</creatorcontrib><collection>CrossRef</collection><jtitle>Galen</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Faramarzzadeh, Reza</au><au>Shariati, Akram</au><au>Shahabi Raberi, Venous</au><au>Masumi, Mehdi</au><au>Tarbiat, Ali</au><au>Rastgoo, Elham</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Regulation of Pyroptosis and Ferroptosis by MicroRNAs in Cardiovascular Diseases</atitle><jtitle>Galen</jtitle><date>2023-08-30</date><risdate>2023</risdate><volume>12</volume><issn>2588-2767</issn><eissn>2322-2379</eissn><abstract>Cardiovascular diseases (CVDs) are considered the most prevalent noncommunicable disease and the leading cause of death worldwide. A plethora of evidence has revealed that microRNAs (miRNAs) could control the inhibition or progression of CVDs by regulating pivotal cell processes ranging from metabolism and homeostasis to programmed cell death (PCD). Pyroptosis and ferroptosis are two major types of nonapoptotic PCDs involved in the pathogenesis of heart failure. However, no study has discussed the crosstalk between miRNAs and these two types of PCDs in the CVDs. The current review demonstrated that different types of miRNAs can regulate both ferroptosis and pyroptosis and thereby affect CVDs progression and inhibition. Altogether, the discussed content encourages further studies to confirm that mentioned pathways are suitable to be considered as novel therapeutic approaches against CVDs.</abstract><doi>10.31661/gmj.v12i.2933</doi></addata></record>
fulltext fulltext
identifier ISSN: 2588-2767
ispartof Galen, 2023-08, Vol.12
issn 2588-2767
2322-2379
language eng
recordid cdi_crossref_primary_10_31661_gmj_v12i_2933
source PubMed (Medline)
title The Regulation of Pyroptosis and Ferroptosis by MicroRNAs in Cardiovascular Diseases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T04%3A37%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Regulation%20of%20Pyroptosis%20and%20Ferroptosis%20by%20MicroRNAs%20in%20Cardiovascular%20Diseases&rft.jtitle=Galen&rft.au=Faramarzzadeh,%20Reza&rft.date=2023-08-30&rft.volume=12&rft.issn=2588-2767&rft.eissn=2322-2379&rft_id=info:doi/10.31661/gmj.v12i.2933&rft_dat=%3Ccrossref%3E10_31661_gmj_v12i_2933%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c843-95bc5db7ab2b69c96b59b1a1bc49ab7006a2c5d6fd432c98bf67679687d8393e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true